Astute Analytica publishes a research report on the Global Regenerative Medicine Market. The analysis report contains in-depth data about demand, growth, opportunities, challenges, and restraints. In addition, it provides a thorough examination of the structure and possibility of global and regional industries.
The Global Regenerative Medicine Market was valued at US$ 49.59 billion in 2022 and is projected to reach a valuation of US$ 375.76 billion by 2031 at a CAGR of 25.86% During the Forecast Period 2023–2031. It analyses the market’s regional trends, size, expansion prospects, and important factors in each region. Additionally, it acknowledges the impact of COVID-19, including updates on the Omicron mutation study, on the market. Both the direct and indirect effects of the pandemic on related industries are taken into account and discussed in the report.
The report gives a thorough analysis of the Global Regenerative Medicine Market, covering regional trends, market size, prospects for expansion, and important market factors in each region. In 2021, the United States Gross Domestic Product (GDP) value was US$ 23,315.08 billion, according to verified data from the World Bank. In terms of GDP, the United States accounts for 10.41% of the global economy. The mixed economy of the United States is very advanced. By nominal GDP, it has the largest economy in the world, and by purchasing power parity (PPP), it is second only to China in size.
The leading companies mentioned are
- Allergan PLC
- Baxter International Inc
- Bayer AG
- Boehringer Ingelheim
- Cesca Therapeutics, Inc.
- F. Hoffmann-La Roche Ltd.
- Fujifilm Corporation
- Medtronic plc
- Merck KGaA
- Mimedx Group Inc
- Novartis AG
- Organogenesis, Inc.
- Osiris Therapeutics
- Pfizer, Inc.
- Takara Bio Inc.
- U.S. Stem Cell, Inc.
- Other Prominent Players
The report also acknowledges the impact of COVID-19, including updates on the Omicron mutation study, on the market. It considers both the direct impact of the pandemic and the indirect influence on related industries. The observations on the pandemic’s impact are included in the report.
Furthermore, the report divides geographical regions into several major categories for production, consumption, revenue (in US dollars), and market share analysis. It discusses the predicted growth of the market in these regions between 2021 and 2031.
The segmentation overview of the Global Regenerative Medicine Market includes
By Product Type
- Gene Therapy
- Cell Therapy
- Stem Cell Therapy
- Autologous Therapy
- Allogenic Therapy
- Tissue-Engineering
- Small Molecules & Biologics
- Others
By Material
- Synthetic material
- Biodegradable synthetic polymers
- Scaffold
- Artificial Vascular Graft
- Hydrogel Material
- Others
- Biologically derived material
- Collagen
- Xenogeneic material
- Others
- Genetically Engineered Material
- Genetically Manipulated Cell
- Transgenics
- Fibroblast
- Neural Stem Cell
- Gene-Activated Matrices
- Others
- Pharmaceutical
- Biologics
- Small Molecules
- Others
By Application
- Dermatology
- Musculoskeletal
- Immunology & Inflammation
- Oncology
- Cardiovascular
- Neurology
- Ophthalmology
- Others
By End User
- Hospitals & Clinics
- Speciality Centers
- Government & Academic Research Institutes
- Others
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- The UK
- Germany
- France
- Italy
- Spain
- Poland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- South America
- Argentina
- Brazil
- Rest of South America